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Abstract
Background—Eliciting patients’ preferences within a framework of shared decision-making
(SDM) has been advocated as a strategy for increasing colorectal cancer (CRC) screening
adherence. Our objective was to assess the effectiveness of a novel decision aid on SDM in the
primary care setting.
Methods—An interactive, computer-based decision aid for CRC screening was developed and
evaluated within the context of a randomized controlled trial. A total of 665 average-risk patients
(mean age, 57 years; 60% female; 63% Black, 6% Hispanics) were allocated to one of two
intervention arms (decision aid alone, decision aid plus personalized risk assessment) or a control
arm. The interventions were delivered just prior to a scheduled primary care visit. Outcome
measures (patient preferences, knowledge, satisfaction with the decision making process [SDMP],
concordance between patient preference and test ordered, and intentions) were evaluated using
pre/post-study visit questionnaires and electronic scheduling.
Results—Overall, 95% of patients in the intervention arms identified a preferred screening
option based on values placed on individual test features. Mean cumulative knowledge, SDMP
and intention scores were significantly higher for both intervention groups compared with the
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control group. Concordance between patient preference and test ordered was 59%. Patients who
preferred colonoscopy were more likely to have a test ordered than those who preferred an
alternative option (83% vs. 70%; P<0.01). Intention scores were significantly higher when the test
ordered reflected patient preferences.
Conclusions—Our interactive computer-based decision aid facilitates SDM but overall
effectiveness is determined by the extent to which providers comply with patient preferences.
Introduction
Colorectal cancer (CRC) is the second leading cause of cancer-related death and third most
commonly diagnosed cancer among men and women in the United States. Screening has
been shown to be a cost-effective strategy for reducing both CRC mortality and incidence1
and is now widely endorsed by most authoritative groups.2, 3 Despite this endorsement,
however, screening rates remain relatively low, partly due to poor patient acceptance and
adherence. Data from the 2005 National Health Interview Survey suggests that while
screening rates have improved, approximately 50% of eligible Americans have not had
appropriate screening.4
Shared decision-making (SDM) has been advocated as a potentially effective strategy for
increasing patient acceptance and adherence to CRC screening recommendations.2, 3 CRC
screening is ideally suited for this approach given the availability of multiple strategies with
distinct advantages and disadvantages, the lack of consensus regarding an optimal strategy,
and historical ineffectiveness of the more traditional paternalistic approach where providers
assume full responsibility for the decision-making process. Further support is derived from
studies that find that patients have distinct preferences for the different screening
strategies,5–18 that providers often misperceive patient preferences,9 and that many patients
support SDM approach for CRC screening.16
SDM is an interactive process in which patients and their health care providers form a
partnership to exchange information, clarify values, and negotiate a mutually agreeable
medical decision.19, 20 Unfortunately, SDM has been difficult to implement into routine
clinical practice in part due to lack of time, lack of clinician expertise and lack of
resources.21 To circumvent several of these barriers, decision aids have been developed to
facilitate informed decision-making (IDM) outside of the clinical encounter.22 IDM is a
process in which patients receive sufficient information about the risks, benefits, limitations,
alternatives and uncertainties of a clinical condition or disease to make a value-concordant
decision and participate in the decision-making process at a desired level. 23, 24 Thus, it is
not as collaborative with the provider as SDM, but still includes a key element of patient
empowerment. As with any decision aid, decision aids for CRC screening should provide, at
a minimum, sufficient information about the pros and cons of the recommended options to
enable users to identify a value-concordant preferred option.25 Besides facilitating IDM,
decision aids also have the potential to facilitate SDM by improving the quality and
efficiency of the patient-provider encounter and by empowering users to participate in the
decision-making process.25 Alternatively, enabling patients to identify a preferred screening
option outside of the clinical encounter could have a detrimental effect on the decision-
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making process in situations where patient and provider preferences differ by inducing
decisional conflict and/or dissatisfaction with the provider recommendation.
Studies to date have clearly demonstrated that existing decision aids for CRC screening
enable users to identify a preferred screening option,6–9, 12, 13, 15–18, 26 reduce decisional
conflict26 and increase interest in screening 8, 10, 13, 15. The extent to which decision aids
facilitate effective SDM and increase adherence, which are of critical importance to the
utility of such tools in clinical practice, however, is less well-established. To address the
former shortcoming, we report herein the interim results of a randomized controlled clinical
trial aimed partly at evaluating the impact of a novel, interactive computer-based decision
aid on relevant measures of SDM, including patient knowledge, patient preferences,
satisfaction with the decision-making process, concordance between patient preference and
test ordered, and screening intentions.
Methods
Decision Aid Development, Format and Usability Testing
Development of our decision aid was guided by constructs of the Ottawa Decision Support
Framework.27, 28 The actual content of the tool was derived from systematic reviews of
available evidence on the cost-effectiveness and attributes of the different screening
strategies,1, 29, 30 a systematic review of existing decision aids25 and expert opinion. We
also conducted a series of focus groups of racially/ethnically diverse previously screened
men (n = 7), previously screened women (n = 10), unscreened men (n = 5) and unscreened
women (n = 9) recruited from a convenience sample of primary care patients seen at the
target sites to determine key factors (e.g., knowledge, attitudes, beliefs, literacy, numeracy,
etc.) that needed to be incorporated in the tool.
The prototype version of the decision aid was built using web-based technology but initially
formatted for DVD use on portable computer stations to provide maximum flexibility for
use in the ambulatory care setting during the clinical trial. The decision aid uses an
audiovisual and touch screen format to simplify use for individuals with limited literacy
and/or computer skills. It is comprised of a series of modules, in which professional actors
playing the role of a black, Hispanic female moderator and a White, non-Hispanic male
physician convey relevant information via on-screen video, animation and/or graphics. The
modules (Figure 1) include: (1) an introductory segment that briefly discusses the
importance of screening, intended purpose of the tool and instructions in its use; (2) an
overview of the epidemiology of CRC, natural history, rationale for screening, benefits of
screening, the availability of multiple screening options, and the lack of consensus regarding
a best screening method; (3) brief descriptions of the five recommended screening methods
(fecal occult blood testing [FOBT], flexible sigmoidoscopy, the combination of FOBT plus
flexible sigmoidoscopy, double-contrast barium enema and colonoscopy) endorsed by the
American Cancer Society, US Preventive Services Task Force and GI Multi-Society Task
Force on Colorectal Cancer at the time 2, 3 ; (4) audio and visual (i.e., traffic light graphic)
comparisons of each screening method with respect to individual test features including
accuracy, inconvenience, discomfort, recommended frequency of testing, complications, and
need (or lack thereof) for further diagnostic studies if the screening test is positive; (5) a
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summary of the different test features for each screening strategy with optional links to more
detailed information about the preparation or test itself, as well as vignettes from a racially
diverse group of patients describing their experience with a particular test; and (6) a
decision-making module where users are asked to identify a screening preference or lack
thereof, using the discrete choice method, rank order test features influencing their selection,
and assess whether out-of-pocket payments (if not covered) would alter their choice; and (7)
a concluding segment in which the narrator encourages the user to discuss screening and
their screening preferences with their doctor, acknowledging that the best CRC screening
test is the test that gets done. Users can navigate forward or backward through the tool using
either the touch screen or a mouse; they also have the option of repeating segments and
printing out key information. Once developed, the tool was reviewed by the Massachusetts
Department of Public Health’s Colorectal Cancer Working Group for content validity and
cultural sensitivity.
A modified version of the decision aid was also created, which includes the web-based
“Your Disease Risk (YDR)” CRC risk assessment tool (http://
www.yourdiseaserisk.wustl.edu). The risk assessment tool was placed just after the
introductory segment. The intent of the tool was to assess the extent to which personalized
risk estimates influenced decision-making. Based on the available literature at the time,31 we
postulated that personalized risk information might positively influence adherence among
patients deemed to be at above average risk.
Usability testing was performed prior to its implementation, in accordance with
recommendations by Nielson,32, 33 to assess ease of learning, efficiency of use, and user
satisfaction. Based on observational data and feedback from two rounds of testing with five
different users per test, the prototype was revised to enhance functionality and deemed ready
for clinical use without further testing.
Study Design
A randomized controlled trial was initiated in April 2005 to evaluate the impact of our
decision aid on SDM and patient adherence to CRC screening recommendations. Eligible
patients were instructed to arrive one hour before a prearranged office visit with their
primary care provider. After obtaining informed consent, patients were administered a
pretest comprised of 28 close-ended questions that assessed knowledge, beliefs, attitudes
and behaviors related to CRC screening, as well as level of desire for participating in
decision-making related to CRC screening.34 The pretest was administered by one of three
trained research assistants in a private office located in one of the ambulatory care clinics at
Boston Medical Center or the South Boston Community Health Center. After completing the
pretest, patients were randomized to one of two intervention arms (decision aid plus YDR
personalized risk assessment tool with feedback or decision aid alone) or a control arm after
stratification by provider. Patients randomized to the control arm reviewed a modified
version of “9 Ways to Stay Healthy and Prevent Disease”, previously posted on the Harvard
Center for Cancer Prevention website, which discussed generic lifestyle changes other than
screening for minimizing risk of preventable diseases. After completing the interactive
computer session, patients then met with their providers to discuss screening and identify a
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preferred screening strategy. Providers received written notification in the form of a flyer
hand delivered by the patient acknowledging that the patient was participating in the “CRC
decision aid” study at the time of the visit to ensure that screening was discussed; no
information was provided preferences or factors influencing choice for patients in the
intervention arm. Before leaving the clinic, subjects were administered a posttest, which
assessed whether CRC screening was discussed, whether a screening strategy was chosen,
patient satisfaction with the decision-making process and screening intentions; the posttest
also re-assessed knowledge, beliefs and attitudes related to CRC screening.
Setting
The study was conducted at two urban ambulatory care sites. The first, Boston Medical
Center, is a private, non-profit academic medical center affiliated with the Boston University
School of Medicine, which serves a mostly minority patient population (only 28% White,
non-Hispanic). The second, the South Boston Community Health Center, is a community
health center affiliated with BMC, which serves a mostly White, non-Hispanic, low income
patient population. Both sites use the same electronic medical record system (Logician). The
study protocols were approved by the Boston University Medical Campus Institutional
Review Board, which was responsible for overseeing human studies research at both
participating institutions.
Study Population and Recruitment Process
The study sample was comprised of average-risk patients under the care of one of the
primary care providers at Boston Medical Center or the South Boston Community Health
Center. Patients were deemed eligible if they were 50 to 75 years of age and had had no
prior structural CRC screening examinations. Potential subjects meeting any of the
following criteria were excluded: (1) prior CRC screening by any method other than FOBT;
(2) high-risk condition (personal history of colorectal cancer or polyps, family history of
colorectal cancer or polyps involving one or more first degree relatives, or chronic
inflammatory bowel disease); (3) lack of fluency in written and spoken English; or (4)
comorbidities that preclude CRC screening by any recommended method.
Three different recruitment strategies were used during the course of the study. The vast
majority of patients (N=637) were recruited using an investigator-initiated “opt-out”
approach in which patients due for screening were identified from monthly audits of Boston
Medical Center’s electronic medical record 2–4 weeks prior to a scheduled office visit and
contacted directly by telephone by one of the research assistants if deemed appropriate by
the patient’s primary care provider. Those expressing interest were provided with a brief
overview of the study, evaluated for eligibility and invited to participate using a passive
informed consent process. Two other strategies, including a provider-initiated, “opt-in”
electronic flagging approach (N=12) and a provider-mediated, “out-in” letter approach
(N=17), were used initially but discontinued after 6 months due to low enrollment. As
opposed to the “opt-out” investigator approach whereby potential subjects could decline to
be recruited after being contacted by the research team without prior permission, the “opt-
in” approach required that potential subjects grant permission to be contacted from the onset
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and a non-response prohibited further communication. The relative cost-effectiveness of
each of our approaches has recently been published.35
Provider Characteristics and Training
Fifty full-time primary care providers, including 47 board-certified general internists and 3
nurse practitioners, practicing at both Boston Medical Center and the South Boston
Community Health Center participated in the study. A pre-trial survey of 30 participating
providers indicated that virtually all (97%) preferred a shared decision-making approach
when selecting an appropriate screening strategy for their patients. Pre-trial seminars were
conducted at both sites to educate providers about the current status of CRC screening
highlighting the recommendation for shared decision-making, provide an overview of the
study design and elicit support. Because of provider turnover, brief annual meetings were
also conducted to insure that new providers were aware of the study, understood its design
and expressed a willingness to participate. The meetings also provided a venue for
informing participating providers about the status of recruitment and addressing any logistic
problems that they were experiencing related to the study. No formal training in shared
decision-making was undertaken.
Outcome Measures
The key outcome measures of interest for assessing the impact of our decision aid on SDM
were patient knowledge, patient preferences, satisfaction with the decision-making process,
screening intentions, and test concordance (i.e., agreement between patient preference and
test ordered).
Knowledge was assessed at baseline (pretest) and at the time of the exit survey (posttest)
based on responses to a 12-item questionnaire (True/False/Don’t know) that inquired about
CRC risk factors, the rationale and goals of screening, and age at which screening should
begin (see Appendix I for individual questions). The content was derived from key
messages endorsed by the National Colorectal Cancer Roundtable 36 and Massachusetts
Department of Public Health 37 for public education. Cumulative knowledge scores (range,
0–12) were derived by summing correct responses to the 12 individual knowledge questions.
Patient preferences and factors influencing choice of options were obtained from response
data captured electronically in the decision aid’s decision-making module.
Patient satisfaction with the decision-making process was assessed on the posttest using the
validated 12-item Satisfaction with the Decision-Making Process scale (Appendix II),38
which has excellent reliability (Cronbach’s α = 0.85) and discriminant validity. Five ordered
response categories were used for each item. Each response was assigned a point score
ranging from 1 for “strongly disagree” (or “poor”) to 5 for “strongly agree” (or “excellent”).
A cumulative score was calculated based on the summed response scores for each item
(maximum score = 60). Mean item substitution was used to impute missing data for patients
answering between 8 and 11 items; patients answering fewer than 8 items were excluded
from analysis.
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Screening intentions were also assessed as part of the posttest. Subjects were asked how sure
they were that they would schedule an appointment to get screened for colorectal cancer and
how sure they were that they would complete the screening test they scheduled. An ordered
5-point response frame was used ranging from “not at all sure” to “completely sure”.
Concordance between patient preferences and test ordered was assessed for the two
intervention groups only since preferences were not elicited from the control group. Test
ordered was ascertained from “Orders” section of the electronic medical record.
Concordance was defined as the percentage of patients who had their preferred screening
test ordered.
Statistical Analyses
Based on crude estimates of baseline adherence, we calculated that a target sample of 825
patients provided 80% power of detecting a 54% vs. 40% pair-wise difference in the percent
of patients completing a CRC screening, using a Bonferroni adjustment to overall alpha
level of 0.05 to account for the three group study design.
As a check on randomization, the three study groups were compared on demographic
characteristics, prior screening, and desired role in decision-making through the chi-square
test of independence. The three study groups were also compared on cumulative pre-test and
post-test knowledge scores, satisfaction with the decision-making process (SDMP) scores
and intention scores through separate one-factor analysis of covariance (ANCOVA);
Bonferroni’s adjusted multiple comparison procedure was used to investigate pairwise
differences following a significant three group comparison. ANCOVA was also used for
subgroup analyses comparing SDMP scores across the three study groups after stratification
by desired role in decision-making (mostly patient, shared, and mostly provider). For the
SDMP analyses, mean item substitution was used to impute missing data for patients who
answered at least 8 items. To evaluate the possible bias of this approach, we employed
multiple imputation analysis to generate 5 data sets using the EM algorithm and found that
the results agreed closely with those derived using mean item substitution. Differences
between study groups on adjusted means from the ANCOVA are described through effect
sizes (d) calculated as the difference in adjusted means divided by the pooled standard
deviation estimate from the ANCOVA. Descriptive statistics were used to describe patient
preferences for the five screening test options and factors influencing choice; associations
between demographic characteristics and patient preferences (colonoscopy versus FOBT)
were examined through a series of multiple logistic regressions. Test concordance, i.e., the
association between patient preference and test ordered, was examined through the chi-
square test of independence. Associations between test concordance and desired role in
decision-making were tested through the chi-square test of independence, whereas
associations between test concordance and both SDMP and intention scores were compared
through the independent sample t-tests. We controlled for study site (Boston Medical Center
and South Boston Community Health Center) in the analyses of all outcome measures, using
ANCOVA regression models for measurement outcomes and Cochran-Mantel-Haenszel
analyses or logistic regression analyses for categorical outcomes. Data are expressed as
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Of the 9648 patients identified as potentially eligible for screening (aged 50–75) for whom
permission to contact was granted, 6542 (68%) were deemed ineligible (mostly due to prior
screening) and 2440 (25%) were excluded. Reasons for exclusion were inability to contact
(n = 2027), disinterest (n = 210), scheduling conflict (n=151), failure to keep appointment (n
= 37), or failure to complete posttest (n= 15) (Figure 2). The remaining 666 patients (62% of
eligible subjects contacted) were enrolled and randomized to decision aid plus Your Disease
Risk (YDR) arm (n = 223), decision aid alone arm (n = 212) or control arm (n = 231).
As shown in Table 1, the three study arms were well-balanced with respect to patient age,
sex, race, ethnicity, education, prior FOBT, insurance status, and decision-making
preference. Overall, the study group was predominantly less than 65 years of age, female,
non-Hispanic, and Black with at least a high school degree. Although most had some form
of health care insurance, nearly two-thirds were covered by Medicare, Medicaid or
Massachusetts’ “free care” program. Most had no prior experience with FOBT. Importantly,
the majority preferred a patient-dominant (28%) or shared decision-making approach (53%)
for selecting a preferred CRC screening option.
Knowledge
Mean [SD] cumulative pretest knowledge scores were comparable (P=0.91) for the 3 groups
(decision aid plus YDR, 7.6 [2.8]; decision aid alone, 7.7 [2.9]; control, 7.5 [2.7]).
Cumulative posttest scores, however, were significantly higher (P<0.001) for the two
intervention groups (decision aid plus YDR, 10.7 [1.8]; decision aid alone, 10.9 [1.6])
compared with the control group (8.6 [2.7]), with differences corresponding to large effect
sizes of d=1.15 and d=1.27 for the decision aid plus YDR group and decision aid alone group
vs. control, respectively. The mean increase in scores from pretest to posttest was also
significant (P<0.001) for both intervention groups (decision aid plus YDR, 3.0 [2.5];
decision aid alone, 3.2 [2.6]) but not the control group (0.8 [2.2]). There were no significant
differences in cumulative posttest scores or change in scores between the two intervention
groups.
Patient Preferences and Factors Influencing Choice
Screening test preferences for patients randomized to the two intervention arms are depicted
in Table 2. Colonoscopy was preferred by a majority of patients (59%) followed by FOBT
(26%), flexible sigmoidoscopy (5%), DCBE (4%) and FOBT plus flexible sigmoidoscopy
(3%); only 3% either declined testing or could not identify a preferred option. No significant
differences were observed between the two intervention groups. Patients who chose
colonoscopy were most likely to identify test accuracy (81%) as the most important feature
influencing their choice; in contrast, patients who chose FOBT were most likely to identify
concerns about discomfort (31%), inconvenience (23%) and bowel preparation (18%) as the
Schroy et al. Page 8






















most influential features. Logistic regression analysis found no significant independent
associations between demographic factors (age, sex, race, ethnicity, education, insurance
status or study site) and preference for colonoscopy versus FOBT [data not shown].
Satisfaction with the Decision-Making Process (SDMP)
Overall, 636 subjects (96% overall) responded to ≥8 items of the SDMP scale and were
included in the analysis; there were no significant differences in the percentage of patients
answering all 12 items vs. 8 to 11 items vs. <8 items (excluded) across the three study
groups (P=0.31). As shown in Table 3, mean SDMP scores were significantly higher for the
two intervention arms compared to controls, with differences corresponding to moderate
effect sizes of 0.53 and 0.61 for the decision aid plus YDR and decision aid alone groups vs.
control, respectively. Scores for the two intervention groups were comparable. Subgroup
analysis found that satisfaction was also higher among intervention patients who preferred a
shared or patient-dominant role in decision-making; a similar trend was observed for
patients who preferred a provider-dominant approach but the differences between the
intervention and control groups did not achieve statistical significance.
Intentions
Mean intention scores [SD] were significantly higher (P<0.001) for the two intervention
groups (decision aid plus YDR, 4.3 [1.0]; decision aid alone, 4.4 [1.0]) compared to the
control group (3.9 [1.4]) when asked “How sure are you that you will schedule a colorectal
cancer screening test?” Mean intention scores were also significantly higher (P<0.001) for
the two intervention groups (both 4.3 [1.0]) compared to controls (3.9 [1.3]) when asked
“How sure are you that you will complete a colorectal cancer screening test?” Differences in
intention to schedule or complete a screening test for the two intervention groups vs. control
correspond to moderate effect sizes ranging between 0.36 and 0.44. Scores were comparable
for the two intervention groups.
Concordance between Patient Preference and Test Ordered
Concordance between preference and test ordered is shown in Table 4. Among the 415
patients expressing a preference, 244 (59%) had their preferred test ordered, 79 (19%) had
an alternate test ordered (colonoscopy, 85%; FOBT, 14%; flexible sigmoidoscopy, 1%), and
92 (22%) had no test ordered. For individual tests, concordance between patient preference
and test ordered varied from 79% for colonoscopy to ≤ 30% for all other options. For the
discordant group, virtually everyone (96%) who preferred a test other than colonoscopy had
a colonoscopy ordered. Patients who preferred colonoscopy were more likely to have any
test ordered than those who preferred a test other than colonoscopy (83% vs. 70%;
P<0.002).
As shown in Table 5, there was no association between concordance and desired role in
decision-making, demonstrating that patients who preferred a patient-dominant or shared
decision-making style were no more likely to have a concordant test ordered than those who
preferred a provider-dominant style. There was also no significant association between
SDMP scores and concordance. Importantly, however, intention scores were significantly
higher when there was concordance between patient preference and test ordered compared
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to when they differed. The positive associations between test concordance and screening
intentions replicated significantly within the independent test-preference groups
(colonoscopy and “other”).
Overall, patients in the intervention arms were more likely to have a test ordered than
patients in the control arm (75% vs. 68%, P<0.05), regardless of whether there was
concordance or discordance with test preference (data not shown). Colonoscopy (82%) was
the most commonly ordered test for control patients with any test ordered followed by
FOBT (12%) and flexible sigmoidoscopy (1%), thus affirming a strong provider preference
for colonoscopy.
Discussion
Most authoritative groups, including the US Preventive Services Task Force, American
Cancer Society, US Multi-Society Task Force on Colorectal Cancer, and American College
of Radiology,2, 3 endorse a SDM approach when selecting an appropriate CRC screening
strategy but implementation into clinical practice encounters many barriers.21 The purpose
of this study was to assess the extent to which use of a novel CRC screening decision aid
circumvents some of these barriers and facilitates effective SDM in the primary care setting.
Like similar such studies, 6–9, 12, 13, 15–18, 26 our study finds that the tool enables users to
identify a preferred screening option based on the relative value they place on individual test
features. Our study also finds that while users are more knowledgeable, more satisfied with
the decision-making process and more intent to undergo screening than non-users overall,
screening intentions and test ordering are negatively influenced in situations where patient
and provider preferences differ, regardless of a patient’s desired role in decision-making.
Together, these observations suggest that the utility of our decision aid for promoting
effective SDM is dependent upon the extent to which providers are willing to comply with
an informed patient’s screening preferences. Importantly, however, screening intentions
were still higher for discordant users than for nonusers, suggesting that use of the decision
aid is nonetheless superior to nonuse.
A critical question that arises when interpreting these findings relates to whether our
outcomes of interest are valid measures of effective SDM. As previously noted, SDM has
been defined as a process in which both the patient and provider engage in information
exchange, deliberation (value clarification), negotiation and mutual decision-making.19, 20
Accordingly, we opted to include patient knowledge, satisfaction with the decision-making
process, concordance between patient preference and test ordered, and screening intentions
as appropriate measures of SDM within the context of this conceptual framework.
The notion of information exchange implies that there was a reciprocal exchange of
information between the patient and health care provider. Because the primary intent of our
decision aid was to educate users about the rationale for screening and the pros and cons of
the different screening options so as to make an informed choice about screening and test
preference, our knowledge outcome is a more reliable measure of IDM than SDM. The
finding that knowledge scores did not increase after the provider encounter for the control
group, however, suggests that most providers failed to convey relevant information about
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the rationale for screening, risk factors, goals and benefits when discussing CRC screening
with their patients.
The SDMP outcome provides a useful measure of patient involvement in the decision-
making process from the patient perspective. As with decision aids for other conditions,25
our findings suggest that our tool also empowered users to participate in the decision-
making process at a desired level, particularly those who preferred a shared or patient-
dominant role in decision-making. We speculate that our tool’s format and inclusion of
specific messages encouraging patients to take a proactive role in the decision-making
process provided meaningful guidance in deliberation and/or communication.
Our concordance and intention outcomes are arguably the most relevant measures of
“effective” SDM. Concordance provides a measure of the extent to which providers are
willing to respect patient autonomy in the decision-making process and comply with patient
preferences when selecting an appropriate screening test. Intention provides a measure of the
degree to which the patient is committed to the chosen course of action and, in the case of
SDM, provides perspective on the extent to which the final decision reflects successful
negotiation and mutual agreement. Intention is also a powerful predictor of CRC screening
adherence.39, 40 In this study, we found that concordance was high for colonoscopy but
relatively low for the other options, suggesting that providers were much more likely to
comply with patient preferences that agreed with their own screening preferences. We also
found that the likelihood of having the preferred test ordered was unaffected by the extent to
which patients wished to engage in the decision-making process, suggesting that most
providers either fail to assess their patients’ desired level of participation or assume
decisional authority, regardless of the preferred role. Perhaps most importantly, we found
that when there was concordance between patient and provider preferences, patients had
stronger screening intentions and a greater likelihood of having any screening test ordered
compared to when patient and provider preferences differed. In the aggregate, these
observations suggest that our decision aid facilitates effective SDM in settings where
providers truly endorse a SDM approach and are willing to comply with patient preferences
when selecting an appropriate screening test. In settings where providers feel compelled to
endorse a single screening option, regardless of patients’ desired level of participation in the
decision-making process, use of the tool may compromise effectiveness, possibly due to
enhanced decisional conflict and/or dissatisfaction with the process or decision itself.
One of the principal goals of both IDM and SDM for CRC screening is the elicitation of a
value-concordant patient preference for one of the recommended screening tests. Our
findings corroborate a body of evidence demonstrating that patients have distinct CRC
screening test preferences that are influenced by the value they place on one or more test
features.5–18 As in our prior study,16 we found that colonoscopy was preferred by a majority
(59%) of intervention patients, most of whom identified test accuracy as the predominant
reason for their selection; in contrast, most of the remaining patients (26%) preferred FOBT
primarily because of concerns about discomfort, inconvenience and bowel preparation. Both
Hawley et al.18 and Marshall et al.17 also observed a dominant preference for colonoscopy
compared to FOBT, flexible sigmoidoscopy and barium enema. Although the surge in media
campaigns promoting colonoscopy in recent years might explain this predilection for
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colonoscopy, a similar trend has not been reported in other recently published studies.12–15
Differences in the study population, options discussed, framing and methodologies used to
elicit preferences may be important factors in accounting for these disparate results.
Collectively, however, these findings support the rationale for eliciting patient preferences
within the context of IDM and/or SDM.
Our study also provides new evidence suggesting that providers also have a dominant
preference for colonoscopy. Using test ordered as a proxy for provider preference, we found
that providers referred the majority (~82%) of control patients for colonoscopy and that
providers were unlikely to order tests other than colonoscopy, regardless of patient
preferences, for the two intervention groups. This predilection for colonoscopy mirrors
national trends in utilization 4 and may be explained by highly publicized studies affirming
superior accuracy for detecting advanced neoplasia compared to other screening
modalities,41–44 expanded coverage by Medicare and many health insurers, and an increase
in patient demand due to heightened public awareness efforts.45 The extent to which liability
concerns, socio-demographic factors, health care coverage, patient co-morbidities and/or
lack of adequate systems for follow-up (as in the case of FOBT) influence provider
recommendations when dealing with individual patients is less well-defined. A reliable risk
prediction model that could accurately stratify patients into different risk categories for the
presence of advanced colorectal adenomas and cancer at screening colonoscopy would be
invaluable in this regard since it would bestow providers with objective decisional support
when considering patient preferences and thereby enhance the effectiveness of SDM. In the
interim, however, the growing tendency to promote colonoscopy independent of patient
preferences undermines the spirit of SDM and its potential effectiveness as a strategy for
increasing CRC screening rates.
Our decision aid has several features that distinguish it from other currently available CRC
screening decision aids. First, the tool employs culturally-sensitive video narratives, simple
graphics and animation to enhance its appropriateness, acceptability and comprehensibility
for use by a diverse target audience with variable literacy skills. Second, it provides an
overview of CRC and CRC screening that incorporates key messages endorsed by the
National Colorectal Cancer Roundtable to heighten awareness and entice interest in
screening.36 Third, one version also incorporates the YDR risk assessment tool to enable
users to incorporate personalized risk estimates into their decision-making. Of note,
however, we observed no significant associations between personalized risk feedback and
patient preferences or other outcomes of interest. We speculate that the lack of difference
between the two intervention arms may be due to the offsetting effects of informing some
patients in the YDR arm that they were at above average risk and others below average risk.
Alternatively, the lack of difference may also be due to the fact that the information was
disregarded by many of those receiving personalized feedback, possibly because it was
perceived to be incorrect.46 Fourth, unlike more complex decision-making approaches, such
as conjoint analysis18 and analytic hierarchy analysis12, 26, the tool employs descriptive
attribute-based comparisons of the different screening tests, as well as option-based
summaries, to enable users to identify a value-concordant preference. Fifth, it provides
optional links to more detailed information about the preparation, test itself and patient
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testimonials to insure that users have as much information as desired to make an informed
choice. Lastly, it provides users with a no screening option and explores reasons for their
decision. The major drawbacks of the tool in its current form are its length, if users opt to
view all segments, and its linear arrangement. Enhancements that permit tailored navigation
to fit the informational needs of users are required for optimal Internet dissemination.
Our study has several notable strengths. First, the study provides new insight into the utility
of decision aids for facilitating SDM related to CRC screening by assessing the extent to
which such tools enhance satisfaction with the decision-making process and the extent to
which concordance between patient preferences and provider preferences influence
screening intentions and test ordering. Second, the use of a randomized controlled study
design, a large sample size, and a racially diverse study population enhances both the
internal and external validity of its findings. Third, implementation of the decision aid as a
point-of-contact intervention attests to the feasibility of use in the primary care setting.
Finally, the inclusion of mostly unscreened patients minimizes the potential confounding.
Our study also has several notable limitations. First, the lack of provider blinding might
have negatively influenced the magnitude of the interventions’ effect on several outcomes of
interest, most notably satisfaction with the decision-making process. Second, no attempt was
made to assess the quality of the patient-provider discussion. Even though satisfaction with
the decision-making process was universally high (albeit higher in the intervention groups),
recent data suggest that most patient-provider discussions related to CRC screening fail to
incorporate key elements of IDM.47–49 Third, no attempt was made to assess factors
influencing provider preferences, as previously noted, nor provider satisfaction related to
either the use of the decision aid or the decision-making process. Fourth, we failed to
explore whether users experienced greater decisional conflict or uncertainty when their
preferences differ from those of their provider. Fifth, we opted to exclude cost information
in our tool when discussing attributes because of conflicting data regarding its impact on
decision-making in this setting7, 50, 51 and because of the complexity of presenting such
information in a meaningful way given the variability in coverage under different health
plans. Lastly, despite its obvious importance, we opted to exclude data on patient adherence
in this interim analysis because of incomplete follow-up. Although extrapolation of our
findings suggests that failure to comply with patient preferences may have negative
consequences on screening behavior, it could be that providers who can effectively
communicate their reasoning for recommending colonoscopy and facilitate its completion
may be successful in getting their patients screened, regardless of their preferences. Existing
data, however, would suggest that providers who focus on colonoscopy tend to adopt a more
paternalistic approach with little exchange of information or attention to barriers.52
In conclusion, our study finds that our decision aid facilitates SDM related to CRC screening
by enabling patients to identify a preferred screening option based on the values they place
on individual test features and screening intentions. Although use of the tool also enhances
satisfaction with the decision-making process, this empowerment may compromise the
effectiveness of SDM in situations where patient and provider preferences differ. Future
studies are needed to better understand factors that influence provider preferences and
identify effective strategies for reconciling these differences. Pending a final analysis of our
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adherence data, our findings suggest that providers who utilize decision aids to facilitate
SDM for CRC screening should be willing to comply with patient preferences when
selecting an appropriate screening test in instances where the patient expresses a desire to
participate in the decision-making process, the choice is informed and there are no
mitigating factors to warrant an alternate recommendation. Failure to do so undermines not
only the spirit of patient-centered decision-making but also the potential effectiveness of
SDM as a strategy for increasing uptake of CRC screening.
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Decision Aid. Representative screens from the different segments of the tool including the
introductory module (A); overview of colorectal cancer and colorectal screening (B); brief
descriptions of each screening option (C); list of test features discussed (D); comparisons of
screening options with respect to individual test features . (E); summaries of attributes for
each option with links to more detailed information about the preparation, procedure itself
and patient testimonials (F); and the decision-making module, where users are asked to
identify a preferred option (G) and rank order test features influencing choice (H). One
version of the tool also includes the “Your Disease Risk” risk assessment tool, which
calculates personalized 10-year estimates for developing CRC (I).
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Study flow diagram. DA, decision aid; YDR, YourDiseaseRisk risk assessment tool
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Table 1
Characteristics of Study Participants (N=666)
Characteristic DA + YCR (n= 223) DA alone (n=212) Control (n=231) P value
Age, n (%) 0.41
 < 65 years 181 (81) 182 (86) 191 (83)
 ≥ 65 years 42 (19) 30 (14) 40 (17)
Sex, n (%) 0.79
 Female 137 (61) 125 (59) 135 (58)
 Male 86 (39) 87 (41) 96 (42)
Ethnicity, n (%) 0.75
 Non-Hispanic 209(94) 202 (95) 217 (94)
 Hispanic 14 (6) 10 (5) 14 (6)
Race, n (%) 0.21
 Black 139 (62) 124 (58) 155 (67)
 White 78 (35) 76 (36) 71 (30)
 Asian 2 (1) 6 (3) 1 (1)
 Other 4 (2) 6 (3) 4 (2)
Education, n (%) 0.56
 ≥ High school 170(76) 159 (76) 165 (73)
 < High school 52 (24) 49 (24) 62 (27)
Insurance, n (%) 0.61
 Private/HMO 78 (39) 73 (39) 77 (36)
 Medicare 65 (33) 47 (25) 66 (31)
 Medicaid 44(22) 54 (29) 53 (25)
 Free care 9 (4) 11 (6) 19 (5)
 None 3 (2) 2 (1) 6 (3)
Prior FOBT 0.90
 Yes 29 (13) 30 (14) 34 (15)
 No 189 (87) 180 (86) 196 (85)
Desired role in decision-making, n (%) 0.68
 Mostly patient 60 (27) 53 (25) 70 (30)
 Shared 120 (54) 120 (57) 115 (50)
 Mostly doctor 43 (19) 39 (18) 46 (20)
DA, Decision Aid; YDR, YourDiseaseRisk; HMO, Health Maintenance Organization; FOBT, fecal occult blood testing.
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Table 3
Satisfaction with the Decision-Making Process (SDMP) Scoresa
DA + YDR DA Alone Control P-value
Overall 50.5 (6.2) 50.7 (6.2) 46.7 (7.9) <0.001b
n = 214 n = 205 (n =217)
Decision-making preference
 Mostly patient 49.4 (6.2) 50.2 (6.5) 46.0 (8.3) 0.01 b
n = 58 n = 50 n = 66
 Shared 50.8 (6.4) 50.6 (6.3) 46.6 (7.9) <0.001 b
n = 115 n = 116 n = 108
 Mostly provider 51.4 (5.4) 51.5 (5.3) 49.0 (6.7) 0.06
n = 41 n = 39 n = 43
DA, Decision Aid; YDR, YourDiseaseRisk
a
Data expressed as mean (SD); maximum score = 60.
b
One-factor ANCOVA showed a significant difference in satisfaction between the three study groups, with pairwise comparisons showing no
significant differences between the two intervention groups and significantly lower satisfaction for those in the control group overall and after
stratification by decision-making preference.

































































































































































































































































































































































































Schroy et al. Page 23
Table 5
Association between test concordance and desired role in decision-making preference, satisfaction with the




Desired role in decision-making, n (%) 0. 9 d
 Mostly patient 60 (75) 20 (25)
 Shared 138 (75) 45 (25)
 Mostly doctor 45 (75) 15 (25)
SDMP score b 51.3 (6.4) 49.4 (5.8) 0.20 e
Intention c










SDMP, satisfaction with the decision-making process
a
Agreement between patient preference and test ordered
b
Mean cumulative scores (SD); maximum = 60
c
Mean scores ± SD where 5= “very sure” and 1 = “very unsure”
d
Cochran-Mantel-Haenszel chi-square analyses controlling for site
e
ANCOVA controlling for site
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